Immunology Company Kira Biotech launches with A$20M Series A Funding
Related Articles
-
Defeat Cancer
Featured in Burwood Scene, June 5, 2013. The capability for professor Derek Hart and his team at Dendritic Cell...
-
ANZAC Research Institute Medical Appeal
Launch Speech by Burwood Scene Editor Belinda Noonan on 29 May 2013. I met Professor Derek Hart at Concord...
-
Abacus Property kick start national cancer medical appeal
Featured in Burwood Scene, June 5, 2013. The owners of Ashfield Mall and Birkenhead Point shopping Centre, Abacus Property...
-
Cancer vaccine closer
Featured in Burwood Scene, March 13, 2013. An anti-cancer vaccine is another step closer as the 20-strong team led...
-
Cancer research panel to be formed
Featured in Burwood Scene, February 17, 2015. Are you a cancer patient, survivor of cancer, carer of someone with cancer...
-
Government supports blood cancer research
Featured in ANZAC Institute Discovery, May 2012. The NSW Government has awarded $3.47 million over 5 years in a...
-
Bendigo Bank Supports ANZAC Research Institute Research Fight for Leukaemia
The Dendritic Cell Biology and Therapeutics Group (DCBTG) at the ANZAC Research Institute is a specialized facility focused on...
-
There’s a knack to raising funds
Featured in Burwood Scene, June 18, 2014. WITHOUT exception there will be a story in every Burwood Scene promoting...
![](mailto:?subject=Immunology Company Kira Biotech launches with A$20M Series A Funding&body=
<img class="aligncenter wp-image-3224 size-medium" src="http://dcresearch.org.au/wp-content/uploads/2019/10/Kira-Biotech-logo-300x150.jpg" alt="" width="300" height="150" /><br />
Brisbane, 29 October 2019: Kira Biotech today announced it has secured Series A funding of A$20 million to develop therapeutics targeting difficult-to-treat immune system disorders.
The round was led by OneVentures, with significant investment from IP Group and support from the Advance Queensland Business Development Fund. The funds will help advance Kira Biotech’s lead candidate KB312 through phase 1 human studies. <a style="color: #ffcc00;" href="https://kirabiotech.com/wp-content/uploads/2019/10/20191024-Kira-Biotech-Series-A-funding-press-release.pdf">Read More</a>
https://dcresearch.org.au/immunology-company-kira-biotech-launches-with-a20m-series-a-funding/){kind=link}